The California Board of Pharmacy reprimanded AmerisourceBergen (ABC) and fined the distributor for shipping “excessive” amounts of opioids and other controlled substances to pharmacies. The company was also cited for failing to report suspicious orders to authorities.

From 2010 through 2015, two facilities in Corona and Valencia, Calif., sold large quantities of such medicines as oxycodone; Norco, which is a mixture of acetaminophen and hydrocodone; Phenergan with codeine syrup, which is a combination narcotic and cough suppressant; and other medicines to several different pharmacies, according to a decision posted on the board website.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy